2-197617826-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_144629.3(RFTN2):c.1024G>A(p.Val342Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000056 in 1,605,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144629.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFTN2 | NM_144629.3 | c.1024G>A | p.Val342Ile | missense_variant | 6/9 | ENST00000295049.9 | NP_653230.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFTN2 | ENST00000295049.9 | c.1024G>A | p.Val342Ile | missense_variant | 6/9 | 1 | NM_144629.3 | ENSP00000295049 | P1 | |
RFTN2 | ENST00000454447.1 | c.70G>A | p.Val24Ile | missense_variant | 1/5 | 3 | ENSP00000387459 | |||
RFTN2 | ENST00000494346.1 | n.196G>A | non_coding_transcript_exon_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151906Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000550 AC: 8AN: 1453988Hom.: 0 Cov.: 27 AF XY: 0.00000415 AC XY: 3AN XY: 723656
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151906Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74188
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.1024G>A (p.V342I) alteration is located in exon 6 (coding exon 6) of the RFTN2 gene. This alteration results from a G to A substitution at nucleotide position 1024, causing the valine (V) at amino acid position 342 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at